LEADER 01580nam  2200385z- 450 
001 9910346749403321
005 20231214133326.0
035   $a(CKB)4920000000094220
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/50694
035   $a(EXLCZ)994920000000094220
100   $a20202102d2018      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aIs the Recent Burst of Therapeutic Anti-Tumor Antibodies the Tip of an Iceberg?
210   $cFrontiers Media SA$d2018
215   $a1 electronic resource (305 p.)
225 1 $aFrontiers Research Topics
311   $a2-88945-462-2 
330   $aThe high effectiveness of antibodies as anti-tumor therapeutic agents has led to a burst of research aiming to increase their therapeutic applications by the use of antibodies against new targets, new antibody formats or new combinations. In this e-book we present relevant research depicting the current efforts in the field.
610   $aantibody formats
610   $aanti-tumor therapeutic antibodies
610   $acheckpoint antibodies
610   $aImmunotherapy
610   $atherapeutic antibodies
610   $aeffective cancer therapies
610   $aantibodies in combinations
700   $aJose A. Garcia-Sanz$4auth$01328794
702   $aLeonor Kremer$4auth
906   $aBOOK
912   $a9910346749403321
996   $aIs the Recent Burst of Therapeutic Anti-Tumor Antibodies the Tip of an Iceberg$93038960
997   $aUNINA